JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chasan-Taber, L.
Right arrow Articles by Stampfer, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chasan-Taber, L.
Right arrow Articles by Stampfer, M. J.

Journal of the American College of Nutrition, Vol 15, Issue 2 136-143, Copyright © 1996 by American College of Nutrition

JOURNAL ARTICLE

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

L. Chasan-Taber, J. Selhub, I. H. Rosenberg, M. R. Malinow, P. Terry, P. V. Tishler, W. Willett, C. H. Hennekens and M. J. Stampfer
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.

OBJECTIVE: To assess prospectively the risk of myocardial infarction (MI) associated with decreased plasma levels of folate and pyridoxal phosphate (PLP, a form of vitamin B6) in relation to elevated levels of total homocysteine (tHcy). DESIGN: Nested case-control study using prospectively collected blood samples. SETTING: Participants in the Physicians' Health Study. SUBJECTS: 14,916 male physicians, aged 40-84 years, with no prior MI or stroke provided plasma samples at baseline and were followed for 7.5 years. Samples from 333 men who subsequently developed MI, and their paired controls matched by age and smoking, were analyzed for folate and PLP levels. MEASURES OF OUTCOME: Acute MI or death due to coronary disease. RESULTS: In a model controlling for diabetes, angina, hypertension, Quetelet's index, and total/high-density lipoprotein cholesterol, men with the lowest 20% of folate levels (< 2.0 ng/mL) had a relative risk of 1.4 (95% confidence interval 0.9-2.3) compared with those in the top 80%. For the lowest 20% of vitamin B6 values, the relative risk was 1.5 (95% CI: 1.0-2.2). When we included both folate and B6 in a model with cardiovascular risk factors, the relative risk of MI for low as compared to high levels of folate was 1.3 (95% CI: 0.8-2.1) and for PLP, 1.3 (95% CI: 0.9-2.1). Adding tHcy to this model did not add significant predictive value (chi sq = 2.0, p > 0.05), except in the first half of the follow-up interval when men with the top 5% of tHcy values had an almost three-fold increase in risk of MI. CONCLUSIONS: Although not statistically significant, these prospective data are compatible with the hypothesis that low dietary intake of folate and/or vitamin B6 contribute to risk of MI.


This article has been cited by other articles:


Home page
 CirculationHome page
J. H. Page, J. Ma, S. E. Chiuve, M. J. Stampfer, J. Selhub, J. E. Manson, and E. B. Rimm
Plasma Vitamin B6 and Risk of Myocardial Infarction in Women
Circulation, August 25, 2009; 120(8): 649 - 655.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
L. L. Humphrey, R. Fu, K. Rogers, M. Freeman, and M. Helfand
Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis
Mayo Clin. Proc., November 1, 2008; 83(11): 1203 - 1212.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. D. Dangour, E. Breeze, R. Clarke, P. S. Shetty, R. Uauy, and A. E. Fletcher
Plasma Homocysteine, but Not Folate or Vitamin B-12, Predicts Mortality in Older People in the United Kingdom
J. Nutr., June 1, 2008; 138(6): 1121 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Moens, C. J. Vrints, M. J. Claeys, J.-P. Timmermans, H. C. Champion, and D. A. Kass
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1971 - H1977.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
J. Ishihara, H. Iso, M. Inoue, M. Iwasaki, K. Okada, Y. Kita, Y. Kokubo, A. Okayama, S. Tsugane, and for the JPHC Study Group
Intake of Folate, Vitamin B6 and Vitamin B12 and the Risk of CHD: The Japan Public Health Center-Based Prospective Study Cohort I
J. Am. Coll. Nutr., February 1, 2008; 27(1): 127 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. Dierkes, C. Weikert, K. Klipstein-Grobusch, S. Westphal, C. Luley, M. Mohlig, J. Spranger, and H. Boeing
Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 214 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
A. S Wierzbicki
Homocysteine and cardiovascular disease: a review of the evidence
Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 143 - 149.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
D. Vanuzzo, L. Pilotto, R. Lombardi, G. Lazzerini, M. Carluccio, S. Diviacco, F. Quadrifoglio, G. Danek, D. Gregori, P. Fioretti, et al.
Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects
Eur. Heart J., February 2, 2007; 28(4): 484 - 491.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. Nasir, M. Tsai, B. D. Rosen, V. Fernandes, D. A. Bluemke, A. R. Folsom, and J. A.C. Lima
Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular Function: The Multi-Ethnic Study of Atherosclerosis
Circulation, January 16, 2007; 115(2): 180 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
H. A. Bischoff, H. B. Staehelin, and W. C. Willett
The effect of undernutrition in the development of frailty in older persons.
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2006; 61(6): 585 - 589.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
O. Higuchi, K. Nakagawa, T. Tsuzuki, T. Suzuki, S. Oikawa, and T. Miyazawa
Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor
J. Lipid Res., May 1, 2006; 47(5): 964 - 974.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. B Bailey
Do low doses of folic acid result in maximum lowering of homocysteine?
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 717 - 718.
[Full Text] [PDF]

Home page
 MutagenesisHome page
B. Smolkova, M. Dusinska, K. Raslova, M. Barancokova, A. Kazimirova, A. Horska, V. Spustova, and A. Collins
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
Mutagenesis, November 1, 2004; 19(6): 469 - 476.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. Voutilainen, J. K Virtanen, T. H Rissanen, G. Alfthan, J. Laukkanen, K. Nyyssonen, J. Mursu, V.-P. Valkonen, T.-P. Tuomainen, G. A Kaplan, et al.
Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study
Am. J. Clinical Nutrition, August 1, 2004; 80(2): 317 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. Friso, D. Girelli, N. Martinelli, O. Olivieri, V. Lotto, C. Bozzini, F. Pizzolo, G. Faccini, F. Beltrame, and R. Corrocher
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 992 - 998.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P.J. Kelly, J.P. Kistler, V.E. Shih, R. Mandell, N. Atassi, M. Barron, H. Lee, S. Silveira, and K.L. Furie
Inflammation, Homocysteine, and Vitamin B6 Status After Ischemic Stroke
Stroke, January 1, 2004; 35(1): 12 - 15.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. T. Merchant, F. B. Hu, D. Spiegelman, W. C. Willett, E. B. Rimm, and A. Ascherio
The Use of B Vitamin Supplements and Peripheral Arterial Disease Risk in Men Are Inversely Related
J. Nutr., September 1, 2003; 133(9): 2863 - 2867.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. El-Khairy, S. E. Vollset, H. Refsum, and P. M. Ueland
Plasma Total Cysteine, Mortality, and Cardiovascular Disease Hospitalizations: The Hordaland Homocysteine Study
Clin. Chem., June 1, 2003; 49(6): 895 - 900.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. J. Kelly, V. E. Shih, J. P. Kistler, M. Barron, H. Lee, R. Mandell, and K. L. Furie
Low Vitamin B6 but Not Homocyst(e)ine Is Associated With Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain Fortification
Stroke, June 1, 2003; 34 (6): e51 - e54.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. Girelli, N. Martinelli, F. Pizzolo, S. Friso, O. Olivieri, C. Stranieri, E. Trabetti, G. Faccini, E. Tinazzi, P. F. Pignatti, et al.
The Interaction between MTHFR 677 C->T Genotype and Folate Status Is a Determinant of Coronary Atherosclerosis Risk
J. Nutr., May 1, 2003; 133(5): 1281 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J. Hung, J. P Beilby, M. W Knuiman, and M. Divitini
Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia
BMJ, January 18, 2003; 326(7381): 131 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
R. Meleady, P. M Ueland, H. Blom, A. S Whitehead, H. Refsum, L. E Daly, S. E. Vollset, C. Donohue, B. Giesendorf, I. M Graham, et al.
Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project
Am. J. Clinical Nutrition, January 1, 2003; 77(1): 63 - 70.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
U. Lim and P. A. Cassano
Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994
Am. J. Epidemiol., December 15, 2002; 156(12): 1105 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom
Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease
Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
A. De Bree, W. M. Verschuren, D. Kromhout, L. I Mennen, H. J Blom, E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, et al.
Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects
Int. J. Epidemiol., December 1, 2002; 31(6): 1268 - 1272.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. Nurk, G. S. Tell, S. E. Vollset, O. Nygard, H. Refsum, and P. M. Ueland
Plasma Total Homocysteine and Hospitalizations for Cardiovascular Disease: The Hordaland Homocysteine Study
Arch Intern Med, June 24, 2002; 162(12): 1374 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. M. Albert, J. Ma, N. Rifai, M. J. Stampfer, and P. M. Ridker
Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death
Circulation, June 4, 2002; 105(22): 2595 - 2599.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M.C. Verhaar, E. Stroes, and T.J. Rabelink
Folates and Cardiovascular Disease
Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 6 - 13.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
P. Knekt, A. Reunanen, G. Alfthan, M. Heliovaara, H. Rissanen, J. Marniemi, and A. Aromaa
Hyperhomocystinemia: A Risk Factor or a Consequence of Coronary Heart Disease?
Arch Intern Med, July 9, 2001; 161(13): 1589 - 1594.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Voutilainen, T. H. Rissanen, J. Virtanen, T. A. Lakka, and J. T. Salonen
Low Dietary Folate Intake Is Associated With an Excess Incidence of Acute Coronary Events : The Kuopio Ischemic Heart Disease Risk Factor Study
Circulation, June 5, 2001; 103(22): 2674 - 2680.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. M. Ridker
High-Sensitivity C-Reactive Protein : Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease
Circulation, April 3, 2001; 103(13): 1813 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 J. Epidemiol. Community HealthHome page
U B Fallon, P Elwood, Y Ben-Shlomo, J B Ubbink, R Greenwood, and G D. Smith
Homocysteine and ischaemic stroke in men: the Caerphilly study
J Epidemiol Community Health, February 1, 2001; 55(2): 91 - 96.
[Abstract] [Full Text]

Home page
 HeartHome page
U B Fallon, Y Ben-Shlomo, P Elwood, J B Ubbink, and G D. Smith
Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up
Heart, February 1, 2001; 85(2): 153 - 158.
[Abstract] [Full Text]

Home page
 StrokeHome page
D. J. Meiklejohn, M. A. Vickers, R. Dijkhuisen, and M. Greaves
Plasma Homocysteine Concentrations in the Acute and Convalescent Periods of Atherothrombotic Stroke
Stroke, January 1, 2001; 32(1): 57 - 62.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
B. K. Nallamothu, A. M. Fendrick, M. Rubenfire, S. Saint, R. R. Bandekar, and G. S. Omenn
Potential Clinical and Economic Effects of Homocyst(e)ine Lowering
Arch Intern Med, December 11, 2000; 160(22): 3406 - 3412.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. S. Morris, P. F. Jacques, I. H. Rosenberg, J. Selhub, B. A. Bowman, E. W. Gunter, J. D. Wright, and C. L. Johnson
Serum Total Homocysteine Concentration Is Related to Self-Reported Heart Attack or Stroke History among Men and Women in the NHANES III
J. Nutr., December 1, 2000; 130(12): 3073 - 3076.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. M. Loria, D. D. Ingram, J. J. Feldman, J. D. Wright, and J. H. Madans
Serum Folate and Cardiovascular Disease Mortality Among US Men and Women
Arch Intern Med, November 27, 2000; 160(21): 3258 - 3262.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. L. Anderson, J. B. Muhlestein, B. D. Horne, J. F. Carlquist, T. L. Bair, T. E. Madsen, and R. R. Pearson
Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease
Circulation, September 12, 2000; 102(11): 1227 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. Brattstrom and D. E. Wilcken
Homocysteine and cardiovascular disease: cause or effect?
Am. J. Clinical Nutrition, August 1, 2000; 72(2): 315 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. M Ueland, H. Refsum, S. A. Beresford, and S. E. Vollset
The controversy over homocysteine and cardiovascular risk
Am. J. Clinical Nutrition, August 1, 2000; 72(2): 324 - 332.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health
Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
T. Omland, A. Samuelsson, M. Hartford, J. Herlitz, T. Karlsson, B. Christensen, and K. Caidahl
Serum Homocysteine Concentration as an Indicator of Survival in Patients With Acute Coronary Syndromes
Arch Intern Med, June 26, 2000; 160(12): 1834 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. K. Hoogeveen, P. J. Kostense, C. Jakobs, J. M. Dekker, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer
Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes : 5-Year Follow-Up of the Hoorn Study
Circulation, April 4, 2000; 101(13): 1506 - 1511.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Arch Intern Med, February 28, 2000; 160(4): 422 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Foody, J. A. Milberg, K. Robinson, G. L. Pearce, D. W. Jacobsen, and D. L. Sprecher
Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 493 - 499.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
R. D. Lindeman, L. J. Romero, K. M. Koehler, H. C. Liang, A. LaRue, R. N. Baumgartner, and P. J. Garry
Serum Vitamin B12, C and Folate Concentrations in the New Mexico Elder Health Survey: Correlations with Cognitive and Affective Functions
J. Am. Coll. Nutr., February 1, 2000; 19(1): 68 - 76.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
P H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, and S B J Ebrahim
Serum total homocysteine and coronary heart disease: prospective study in middle aged men
Heart, October 1, 1999; 82(4): 448 - 454.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. D. Kark, J. Selhub, B. Adler, J. Gofin, J. H. Abramson, G. Friedman, and I. H. Rosenberg
Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem
Ann Intern Med, September 7, 1999; 131(5): 321 - 330.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. W. Eikelboom, E. Lonn, J. Genest Jr., G. Hankey, and S. Yusuf
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Ann Intern Med, September 7, 1999; 131(5): 363 - 375.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. J. Harjai
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Ann Intern Med, September 7, 1999; 131(5): 376 - 386.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. M. Ridker
Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ann Intern Med, June 1, 1999; 130(11): 933 - 937.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. M. Ridker, J. E. Manson, J. E. Buring, J. Shih, M. Matias, and C. H. Hennekens
Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women
JAMA, May 19, 1999; 281(19): 1817 - 1821.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. K. Osganian, M. J. Stampfer, D. Spiegelman, E. Rimm, J. A. Cutler, H. A. Feldman, D. H. Montgomery, L. S. Webber, L. A. Lytle, L. Bausserman, et al.
Distribution of and Factors Associated With Serum Homocysteine Levels in Children: Child and Adolescent Trial for Cardiovascular Health
JAMA, April 7, 1999; 281(13): 1189 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. D. A. Stehouwer, M. P. Weijenberg, M. van den Berg, C. Jakobs, E. J. M. Feskens, and D. Kromhout
Serum Homocysteine and Risk of Coronary Heart Disease and Cerebrovascular Disease in Elderly Men : A 10-Year Follow-Up
Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1895 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
P. W. Siri, P. Verhoef, and F. J. Kok
Vitamins B6, B12, and Folate: Association with Plasma Total Homocysteine and Risk of Coronary Atherosclerosis
J. Am. Coll. Nutr., October 1, 1998; 17(5): 435 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. W. Jacobsen
Homocysteine and vitamins in cardiovascular disease
Clin. Chem., August 1, 1998; 44(8): 1833 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. R. Folsom, F. J. Nieto, P. G. McGovern, M. Y. Tsai, M. R. Malinow, J. H. Eckfeldt, D. L. Hess, and C. E. Davis
Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins : The Atherosclerosis Risk in Communities (ARIC) Study
Circulation, July 21, 1998; 98(3): 204 - 210.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. S. Omenn, S. A. A. Beresford, and A. G. Motulsky
Preventing Coronary Heart Disease : B Vitamins and Homocysteine
Circulation, February 10, 1998; 97(5): 421 - 424.
[Full Text] [PDF]

Home page
 JAMAHome page
E. B. Rimm, W. C. Willett, F. B. Hu, L. Sampson, G. A. Colditz, J. E. Manson, C. Hennekens, and M. J. Stampfer
Folate and Vitamin B6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women
JAMA, February 4, 1998; 279(5): 359 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. W. Evans, B. J. Shaten, J. D. Hempel, J. A. Cutler, and L. H. Kuller
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1947 - 1953.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. Verhoef, F. J. Kok, D. A.C.M. Kruyssen, E. G. Schouten, J. C.M. Witteman, D. E. Grobbee, P. M. Ueland, and H. Refsum
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 989 - 995.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. Ma, M. J. Stampfer, C. H. Hennekens, P. Frosst, J. Selhub, J. Horsford, M. R. Malinow, W. C. Willett, and R. Rozen
Methylenetetrahydrofolate Reductase Polymorphism, Plasma Folate, Homocysteine, and Risk of Myocardial Infarction in US Physicians
Circulation, November 15, 1996; 94(10): 2410 - 2416.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Nutrition.